Previous Article | Next Article ![]()
Mol. Cell. Biol., Aug 1997, 4501-4508, Vol 17, No. 8
LC Bullions, DA Notterman, LS Chung and AJ Levine
Recent studies indicate that disruption of the E-cadherin-mediated cell-
cell adhesion system is frequently associated with human cancers of
epithelial origin. Reduced levels of both E-cadherin and the associated
protein, alpha-catenin, have been reported in human tumors. This report
describes the characterization of a human ovarian carcinoma-derived cell
line (Ov2008) which expresses a novel mutant form of the alpha- catenin
protein lacking the extreme N terminus of the wild-type protein. The
altered form of alpha-catenin expressed in Ov2008 cells fails to bind
efficiently to beta-catenin and is localized in the cytoplasm. Deletion
mapping has localized the beta-catenin binding site on alpha-catenin
between amino acids 46 and 149, which encompasses the same region of the
protein that is deleted in the Ov2008 variant. Restoration of inducible
expression of the wild-type alpha-catenin protein in these cells caused
them to assume the morphology typical of an epithelial sheet and retarded
their growth in vitro. Additionally, the induction of alpha-catenin
expression in Ov2008 cells injected into nude mice attenuated the ability
of these cells to form tumors. These observations support the
classification of alpha-catenin as a growth- regulatory and candidate tumor
suppressor gene.
Copyright © 1997, American Society for Microbiology
Expression of wild-type alpha-catenin protein in cells with a mutant alpha-catenin gene restores both growth regulation and tumor suppressor activities
Department of Molecular Biology, Princeton University, New Jersey 08544, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»